scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANA.410440407 |
P698 | PubMed publication ID | 9778260 |
P50 | author | Anthony Lang | Q47504039 |
Jonathan Dostrovsky | Q60977333 | ||
William Hutchison | Q67501010 | ||
Andres Lozano | Q23713628 | ||
P2093 | author name string | Levy R | |
Opitz H | |||
Allan RJ | |||
P433 | issue | 4 | |
P921 | main subject | Parkinson's disease | Q11085 |
subthalamic nucleus | Q2270424 | ||
neurophysiology | Q660910 | ||
P304 | page(s) | 622-628 | |
P577 | publication date | 1998-10-01 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease | |
P478 | volume | 44 |
Q47618063 | A Computerized Microelectrode Recording to Magnetic Resonance Imaging Mapping System for Subthalamic Nucleus Deep Brain Stimulation Surgery. |
Q51801704 | A comparison of two surgical approaches in functional neurosurgery: individualized versus conventional stereotactic frames. |
Q28307713 | AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial |
Q48933791 | Accuracy of customized miniature stereotactic platforms |
Q47761354 | Accuracy of subthalamic nucleus targeting by T2, FLAIR and SWI-3-Tesla MRI confirmed by microelectrode recordings |
Q36316264 | Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease |
Q40164155 | An Unsupervised Online Spike-Sorting Framework |
Q35589979 | Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. |
Q50244570 | Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats |
Q29994716 | Antiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges |
Q39265062 | Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata |
Q34127250 | Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients |
Q42316432 | Applying Microelectrode Recordings in Neurosurgery |
Q37261589 | Asymmetric right/left encoding of emotions in the human subthalamic nucleus |
Q89867686 | Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson's Disease |
Q48512908 | Automatic analysis and visualization of microelectrode recording trajectories to the subthalamic nucleus: preliminary results |
Q46715123 | Balance of monosynaptic excitatory and disynaptic inhibitory responses of the globus pallidus induced after stimulation of the subthalamic nucleus in the monkey. |
Q35844074 | Basal ganglia dysfunction in OCD: subthalamic neuronal activity correlates with symptoms severity and predicts high-frequency stimulation efficacy |
Q35040203 | Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease |
Q42501960 | Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease |
Q35971349 | Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl |
Q46847061 | Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson's disease |
Q57814743 | Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long-term follow-up of patients |
Q37217976 | Brain penetration effects of microelectrodes and DBS leads in STN or GPi |
Q42007550 | Changes in GABA and glutamate concentrations during memory tasks in patients with Parkinson's disease undergoing DBS surgery. |
Q49144710 | Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. |
Q36045515 | Characterizing the spiking dynamics of subthalamic nucleus neurons in Parkinson's disease using generalized linear models |
Q37405538 | Closing the loop of deep brain stimulation |
Q37217333 | Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial |
Q92862421 | Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease |
Q48553283 | Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. |
Q37628270 | Complications of deep brain stimulation: a collective review |
Q34199513 | Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. |
Q44156245 | Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. |
Q36337189 | Contribution of inter-muscular synchronization in the modulation of tremor intensity in Parkinson's disease. |
Q34515608 | Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. |
Q47192561 | Decreased Power but Preserved Bursting Features of Subthalamic Neuronal Signals in Advanced Parkinson's Patients under Controlled Desflurane Inhalation Anesthesia |
Q33205100 | Deep brain stimulation |
Q81034320 | Deep brain stimulation for Parkinson's disease |
Q48405825 | Deep brain stimulation for the treatment of Parkinson's disease. |
Q34010754 | Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial |
Q35463234 | Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters |
Q35475589 | Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts |
Q35464937 | Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation |
Q43531893 | Deep brain stimulation therapy for Parkinson's disease using frameless stereotaxy: comparison with frame-based surgery. |
Q31058824 | Deep brain stimulation: overview and update |
Q42518062 | Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa |
Q42521622 | Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease |
Q34133705 | Depth-time interpolation of feature trends extracted from mobile microelectrode data with kernel functions |
Q48235829 | Detection of boundaries of subthalamic nucleus by multiple-cell spike density analysis in deep brain stimulation for Parkinson's disease. |
Q51976207 | Different functional loops between cerebral cortex and the subthalmic area in Parkinson's disease. |
Q48906038 | Direction and predictive factors for the shift of brain structure during deep brain stimulation electrode implantation for advanced Parkinson's disease |
Q42508832 | Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease |
Q36256517 | Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements |
Q31826825 | Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. |
Q47826520 | Dopamine-dependent scaling of subthalamic gamma bursts with movement velocity in patients with Parkinson's disease. |
Q35572061 | Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons |
Q73011796 | Double blinded evaluation of the effects of pallidal and subthalamic nucleus stimulation on daytime activity in advanced Parkinson's disease |
Q52095541 | Effect of Eye Opening on Single-Unit Activity and Local Field Potentials in the Subthalamic Nucleus. |
Q36507071 | Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease |
Q42450852 | Effect of subthalamic lesion with kainic acid on the neuronal activities of the basal ganglia of rat Parkinsonian models with 6-hydroxydopamine |
Q48589791 | Electrophysiological localization of the subthalamic nucleus in parkinsonian patients |
Q51677106 | Electrophysiological validation of STN-SNr boundary depicted by susceptibility-weighted MRI. |
Q64861640 | Event-related deep brain stimulation of the subthalamic nucleus affects conflict processing. |
Q42521116 | Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling |
Q34330022 | Extrastriatal dopaminergic circuits of the Basal Ganglia |
Q42471859 | Eye movement-related responses of neurons in human subthalamic nucleus |
Q64066649 | Fast Intracortical Sensory-Motor Integration: A Window Into the Pathophysiology of Parkinson's Disease |
Q42482253 | Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients |
Q43546769 | Frequency-dependent effects of electrical stimulation in the globus pallidus of dystonia patients |
Q34605499 | From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control |
Q35627878 | Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease |
Q38166648 | Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications |
Q46586668 | Globus pallidus neurons dynamically regulate the activity pattern of subthalamic nucleus neurons through the frequency-dependent activation of postsynaptic GABAA and GABAB receptors. |
Q33943024 | Hidden semi-Markov models in the computerized decoding of microelectrode recording data for deep brain stimulator placement |
Q37824441 | High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review |
Q42474478 | High-frequency microstimulation in human globus pallidus and substantia nigra |
Q48650051 | High-frequency oscillations in Parkinson's disease: spatial distribution and clinical relevance |
Q48437934 | High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease |
Q33920933 | High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor |
Q48720499 | Higher neuronal discharge rate in the motor area of the subthalamic nucleus of Parkinsonian patients |
Q24650187 | Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgery |
Q35475316 | Identification of target areas for deep brain stimulation in human basal ganglia substructures based on median nerve sensory evoked potential criteria |
Q38596525 | Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity |
Q21147053 | Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus |
Q34325883 | Immunotoxin-mediated tract targeting in the primate brain: selective elimination of the cortico-subthalamic "hyperdirect" pathway |
Q73986070 | Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions |
Q42444789 | Increased gamma oscillatory activity in the subthalamic nucleus during tremor in Parkinson's disease patients |
Q34208352 | Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus. |
Q34596437 | Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease |
Q48633778 | Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease |
Q30978960 | Invasive recordings from the human brain: clinical insights and beyond |
Q42451698 | Involvement of Human Thalamic Neurons in Internally and Externally Generated Movements |
Q33633995 | Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. |
Q48151517 | Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans |
Q35028340 | Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson's disease. |
Q48159444 | Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease |
Q53418820 | Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion. |
Q41611311 | Lesion of subthalamic nucleus in parkinsonian rats : effects of dopamine d(1) and d(2) receptor agonists on the neuronal activities of the substantia nigra pars reticulata |
Q46218711 | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients |
Q36873493 | Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications |
Q37458513 | Local field potential recordings in a non-human primate model of Parkinsons disease using the Activa PC + S neurostimulator |
Q38757044 | Local vs. volume conductance activity of field potentials in the human subthalamic nucleus |
Q41549333 | Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. |
Q35560325 | MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease |
Q42044413 | Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones |
Q42486829 | Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. |
Q43767019 | Metabolic changes following subthalamotomy for advanced Parkinson's disease |
Q47313656 | Microelectrode recording duration and spatial density constraints for automatic targeting of the subthalamic nucleus |
Q37882596 | Milestones in Parkinson's disease therapeutics |
Q41313568 | Movement-Related Activity of Human Subthalamic Neurons during a Reach-to-Grasp Task |
Q48226549 | Multicenter study report: electrophysiological monitoring procedures for subthalamic deep brain stimulation surgery in Parkinson's disease. |
Q36082849 | Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons. |
Q48892559 | Multiple-cell spike density and neural noise level analysis by semimicroelectrode recording for identification of the subthalamic nucleus during surgery for Parkinson's disease |
Q38771142 | Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research |
Q42440284 | Neuronal activity in the medial associative-limbic and lateral motor part of the rat subthalamic nucleus and the effect of 6-hydroxydopamine-induced lesions of the dorsolateral striatum |
Q42440222 | Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. |
Q50654152 | Neuronal activity of the red nucleus in Parkinson's disease. |
Q48619132 | Neuronal activity of the zona incerta in Parkinson's disease patients |
Q47252951 | Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease |
Q35924076 | Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. |
Q48544924 | Neuronal response to local electrical stimulation in rat thalamus: physiological implications for mechanisms of deep brain stimulation |
Q37965966 | Neurophysiologic intervention in deep brain stimulation treatment for movement disorders: a practical framework |
Q34669765 | Neurophysiological correlate of clinical signs in Parkinson's disease |
Q48101223 | Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. |
Q48302339 | New developments in understanding the etiology of Parkinson's disease and in its treatment |
Q42510587 | Oscillatory entrainment of subthalamic nucleus neurons and behavioural consequences in rodents and primates |
Q41294649 | PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study |
Q57298507 | Passive limb movement test facilitates subthalamic deep brain stimulation under general anesthesia without influencing awareness |
Q34596340 | Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back |
Q34596357 | Pathophysiology of dystonia: a neuronal model |
Q47839448 | Pedunculopontine nucleus microelectrode recordings in movement disorder patients |
Q34826234 | Physiologic studies in the human brain in movement disorders |
Q44898080 | Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus |
Q37294450 | Point process modeling reveals anatomical non-uniform distribution across the subthalamic nucleus in Parkinson's disease |
Q48974095 | Potentials recorded at the scalp by stimulation near the human subthalamic nucleus |
Q36881302 | Prediction of STN-DBS Electrode Implantation Track in Parkinson's Disease by Using Local Field Potentials |
Q97519830 | Randomized, Double-Blind Assessment of LFP Versus SUA Guidance in STN-DBS Lead Implantation: A Pilot Study |
Q38230498 | Reassessing models of basal ganglia function and dysfunction |
Q60198376 | Regularizing firing patterns of rat subthalamic neurons ameliorates parkinsonian motor deficits |
Q48308115 | Repetitive activation of glutamatergic inputs evokes a long-lasting excitation in rat globus pallidus neurons in vitro |
Q42518609 | Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats |
Q42437678 | Signals through the striatopallidal indirect pathway stop movements by phasic excitation in the substantia nigra. |
Q44902278 | Single pulse stimulation of the human subthalamic nucleus facilitates the motor cortex at short intervals |
Q33893379 | Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients |
Q42474145 | Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque |
Q36642007 | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD). |
Q46477677 | Stereotactic biopsy with electrical monitoring for deep-seated brain tumors |
Q33838475 | Stimulation of contacts in ventral but not dorsal subthalamic nucleus normalizes response switching in Parkinson's disease |
Q35973431 | Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. |
Q44633144 | Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release |
Q42456203 | Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus |
Q39317497 | Stop! border ahead: Automatic detection of subthalamic exit during deep brain stimulation surgery |
Q42515992 | Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway'. |
Q42322107 | Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson's Disease Patients |
Q41664899 | Subthalamic Nucleus Deep Brain Stimulation: Basic Concepts and Novel Perspectives. |
Q47953391 | Subthalamic discharges as a causal determinant of parkinsonian motor deficits |
Q42487231 | Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease |
Q48363259 | Subthalamic nucleus deep brain stimulation improves saccades in Parkinson's disease |
Q30650561 | Subthalamic nucleus deep brain stimulation: an invaluable role for MER. |
Q48476339 | Subthalamic nucleus deep brain stimulus evoked potentials: physiological and therapeutic implications |
Q35150956 | Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression |
Q36904578 | Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease |
Q48491668 | Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts. |
Q36088279 | Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold |
Q49076255 | Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease |
Q48489632 | Subthalamic oscillatory activity in parkinsonian patients with off-period dystonia |
Q48172022 | Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease |
Q42511761 | Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease |
Q48392830 | Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata. |
Q36577302 | Surgery insight: Deep brain stimulation for movement disorders |
Q35568788 | Surgery of the Subthalamic Nucleus: Use of Movement-related Neuronal Activity for Surgical Navigation |
Q42519525 | Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. |
Q48035613 | Targeting Accuracy of the Subthalamic Nucleus in Deep Brain Stimulation Surgery: Comparison Between 3 T T2-Weighted Magnetic Resonance Imaging and Microelectrode Recording Results. |
Q40009826 | Teaching neurons to respond to placebos |
Q48330226 | Thalamic single-unit and local field potential activity in Tourette syndrome |
Q35885494 | The Cerebellum and Basal Ganglia are Interconnected |
Q50739085 | The Insertion of Electrodes in the Brain for Electrophysiological Recording or Chronic Stimulation Is Not Associated With Any Biochemically Detectable Neuronal Injury. |
Q48032414 | The Relationship of Electrophysiologic Subthalamic Nucleus Length as a Predictor of Outcomes in Deep Brain Stimulation for Parkinson Disease |
Q38188451 | The T-type calcium channel as a new therapeutic target for Parkinson's disease. |
Q48389093 | The anatomical and electrophysiological subthalamic nucleus visualized by 3-T magnetic resonance imaging |
Q45875317 | The changing landscape of surgery for Parkinson's Disease |
Q40800246 | The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease. |
Q38646295 | The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'? |
Q30498199 | The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys |
Q36117508 | The effects of cues on neurons in the basal ganglia in Parkinson's disease |
Q59281315 | The effects of different anesthetic methods on neuronal activity and movement symptoms of Parkinson’s disease |
Q35593737 | The emergence of single neurons in clinical neurology |
Q48335838 | The human subthalamic nucleus and globus pallidus internus differentially encode reward during action control |
Q41235188 | The integrative role of the pedunculopontine nucleus in human gait |
Q42464599 | The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease |
Q48453962 | The oscillatory activity in the Parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation. |
Q36137988 | The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention |
Q33816549 | The subthalamic nucleus in primary dystonia: single-unit discharge characteristics |
Q42472598 | Timing and direction selectivity of subthalamic and pallidal neurons in patients with Parkinson disease |
Q62491964 | Toward Electrophysiology-Based Intelligent Adaptive Deep Brain Stimulation for Movement Disorders |
Q38207526 | Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action. |
Q48484297 | Tremor entrainment by patterned low-frequency stimulation |
Q92217378 | Understanding Parkinson's disease and deep brain stimulation: Role of monkey models |
Q48428197 | Unilateral pedunculopontine stimulation improves falls in Parkinson's disease |
Q39068585 | Using "Functional" Target Coordinates of the Subthalamic Nucleus to Assess the Indirect and Direct Methods of the Preoperative Planning: Do the Anatomical and Functional Targets Coincide? |
Q37294466 | Using point process models to compare neural spiking activity in the subthalamic nucleus of Parkinson's patients and a healthy primate |
Q35869489 | Validity of single tract microelectrode recording in subthalamic nucleus stimulation |
Q51635606 | Very fast oscillations evoked by median nerve stimulation in the human thalamus and subthalamic nucleus. |
Q42471881 | Visually guided movements suppress subthalamic oscillations in Parkinson's disease patients. |
Q64859366 | What Is the Best Electrophysiologic Marker of the Outcome of Subthalamic Nucleus Stimulation in Parkinson Disease? |
Q64860779 | [Deep brain stimulation using simultaneous stereotactic electrode placement: an alternative to conventional functional stereotaxy?] |
Search more.